Jommi, C. and Ravasio, R. (2019) “The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)”, AboutOpen, 6(1), pp. 78–85. doi: 10.33393/abtpn.2019.302.